Shares of Carvana Co. fell 11% on Friday after activist short seller Hindenburg Research published a report accusing the Tempe-based used car retailer of lax car loan underwriting practices ...

Hindenburg Research, a well-known short seller, has targeted Carvana with allegations that its recent financial recovery is built on shaky foundations. The firm accused Carvana of relying on ...

Carvana Co. ( NYSE: CVNA ) shares tumbled nearly 13% during the two days ended Jan. 3, 2025 as the market digested a scathing report published by Hindenburg Research on Jan. 2, 2025. Hagens Berman ...

Notorious short seller Hindenburg Research has targeted online used car retailer Carvana (CVNA), calling the company’s turnaround strategy a “mirage.” The report by Hindenburg Research ...

Carvana Co. shares dived, dropping 11% last Friday, after a scathing report from Hindenburg Research emerged, casting a heavy shadow on the company's claimed financial turnaround. The Tempe-based ...

Hindenburg Research has accused the auto retailer Carvana of engaging in financial fraud. The firm claims Carvana manipulated its financial statements and misled investors about its financial health.

A median of 54% of adults across 36 nations say the gap between the rich and the poor is a very big problem in their country. Most believe that rich people having too much political influence ...

Jan. 9, 2025 — Antibiotic-resistant Salmonella is a serious public health concern that has increased in recent years as the bacteria have developed ways to survive drugs. According to the U.S ...

The corticotropic-releasing hormone enhances the bone-marrow homing and engraftment of human haematopoietic stem and progenitor cells via the mechanical remodelling of the cell’s cytoskeleton ...

Availability of convenient starting materials is critical to advance actinide research. Here, we highlight four contributions published in 2024 which have aided the development of new starting ...

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research ...

Morningstar’s independent research is only biased in favor of investors. Dig into expert analysis from 100+ global researchers on securities, funds, markets, and portfolios. With transparent ...